M&A adds fuel to the fire

Big Spenders

M&A adds fuel to the fire

Many biotechs making the shift from toolkit models or early stage research to more fully integrated product development companies are doing so with the help of mergers and acquisitions. But while M&A adds pieces of the value chain, it also can add significant costs. Thus, it bears repeating that acquirers need to move quickly to retain the assets they need and divest those they don't.

Edward Lanphier, president and CEO of zinc finger protein company Sangamo BioSciences Inc. (SGMO,

Read the full 855 word article

How to gain access

Continue reading with a
two-week free trial.